文献速递临床试验与 GCP

针灸治疗导管消融后持续性房颤:一项预试验随机对照试验的研究方案

Acupuncture for persistent atrial fibrillation after catheter ablation: study protocol for a pilot randomized controlled trial.
PubMed 文献 · Trials · 2021-01-07

所有患者导管消融后接受18次针灸治疗,主要结局为6个月时房颤负荷,旨在评估针灸减少房颤负荷的可行性、初步疗效和安全性。

要点

  • 预试验评估针灸减少导管消融后持续性房颤负荷的可行性、初步疗效与安全性。
  • 主要结局为6个月时房颤负荷,通过7天连续动态心电监测贴片测量。

核心结论

  • 本预试验将评估针灸减少持续性房颤导管消融后房颤负荷的可行性、初步疗效和安全性。
  • 结果将用于后续大规模试验的样本量计算。

研究设计与样本

  • 多中心、三臂、预试验随机对照试验,在中国开展。
  • 研究周期6个月,包括3个月治疗期和3个月随访期。
  • 所有患者消融后接受18次针灸治疗,持续12周,并接受适当的消融后常规治疗。

关键数值与推荐

  • 主要结局为导管消融后6个月时房颤负荷,通过可进行7天连续动态心电监测的心电贴片测量。
  • 次要结局包括导管消融后3个月时房颤负荷、房颤复发、生活质量等,并记录不良事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Atrial fibrillation (AF) is a common arrhythmia, which is closely related to cardiovascular morbidity and mortality. Although acupuncture is used in the treatment of AF, the evidence is insufficient. The objective of this pilot trial is to evaluate the feasibility, preliminary efficacy, and safety of acupuncture in reducing AF burden for persistent AF after catheter ablation (CA). METHODS AND DESIGN: This will be a multi-center, 3-arm, pilot randomized controlled trial in China. Sixty patients in total will be randomly assigned to the specific acupoints group, the non-specific acupoints group, or the non-acupoints group in a 1:1:1 ratio. The whole study period is 6 months, including a 3-month treatment period and a 3-month follow-up period. All patients will receive 18 sessions of acupuncture over 12 weeks after CA and appropriate post-ablation routine treatment. The primary outcome is AF burden at 6 months after CA measured by electrocardiography patch that can carry out a 7-day continuous ambulatory electrocardiographic monitoring. The secondary outcomes include AF burden at 3 months after CA, recurrence of AF, quality of life, etc. The adverse events will also be recorded. DISCUSSION: This pilot study will contribute to evaluating the feasibility, preliminary efficacy, and safety of acupuncture in reducing AF burden for persistent AF after CA. The results will be used for the sample size calculation of a subsequent large-scale trial. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2000030576 . Registered on 7 March 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Lin Y, Wang X, Li XB, et al. Acupuncture for persistent atrial fibrillation after catheter ablation: study protocol for a pilot randomized controlled trial. Trials. 2021. PMID: 33413569. doi:10.1186/s13063-020-04967-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。